Compare Humana Inc (HUM) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Royal Caribbean Cruises Ltd — how do they compare? Humana Inc trades at $406.5 (market cap $47.81B), while Royal Caribbean Cruises Ltd trades at $287.61 (market cap $76.75B). The key difference: Royal Caribbean Cruises Ltd is the larger of the two by market cap, and Royal Caribbean Cruises Ltd pays the higher dividend (1.75%). Which is the better fit depends on your goals.
| HUM | RCL | |
|---|---|---|
Market Cap | $47.81B | $76.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $365.84 |
52-Week Low | $163.67 | $246.71 |
Enterprise Value | $56.85B | $98.03B |
Dividend Yield | 0.89% | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Royal Caribbean (RCL) trades at $285.59, down 0.48% on the day, with technical indicators showing a neutral to bullish bias as the stock tests support near $285. Fundamentally, the company demonstrates strong profitability with 24.36% net margins and 50.41% ROE, supported by robust revenue growth from $8.8B in 2022 to $17.93B in 2025. Recent earnings have mostly beaten expectations, with Q1 2026 EPS of $3.60 surpassing estimates of $3.24.
The investment outlook remains positive given analyst consensus price target of $328 (15% upside), strong cash flow generation, and continued recovery in cruise demand. Key risks include high debt levels ($18.47B long-term debt), sensitivity to economic cycles, and competitive pressures in the cruise industry. The upcoming Q2 2026 earnings report on July 28 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →
